Plasma p‐tau217 and p‐tau217/Aβ1‐42 are effective biomarkers for identifying CSF‐ and PET imaging‐diagnosed Alzheimer's disease: Insights for research and clinical practice

Xiaomei Zhong(Guangzhou Medical University), Yuping Ning(Guangzhou Medical University)

Alzheimer s & Dementia

January 30, 2025

10.1002/alz.14536

Cited by 51

Related Papers

Abnormal Serum Bilirubin/Albumin Concentrations in Dementia Patients With Aβ Deposition and the Benefit of Intravenous Albumin Infusion for Alzheimer’s Disease Treatment

|Frontiers in Neuroscience|2020|29

Ginsenoside Rd protects against acute liver injury by regulating the autophagy NLRP3 inflammasome pathway

|Scientific Reports|2025|5